Meningococcal Disease – A Guide for Healthcare Professionals
Meningococcal disease progresses very rapidly. Deaths can occur in as little as a few hours. The disease is caused by the bacterium Neisseria meningitidis. The most common strains worldwide are A, B, C, W and Y. In 2017 both MenW and MenB cases dramatically increased.
The Meningococcal Disease – A Guide for Healthcare Professionals provides useful information about clinical features of the disease, as well as information on epidemiology, transmission, and vaccination recommendations.
Click on the image below to view or download the 2020 Meningococcal Disease – A Guide for Healthcare Professionals.
REFERENCES for Meningococcal Guide:
1 Meningococcal vaccines for Australians/ NCIRS Fact sheet: 1 July 2020.
2 Australian Government Department of Health; Invasive Meningococcal Disease National Surveillance Report-Quarter 4 2018, 1 October 2018 to 31 December 2018.
3 Australian Government Department of Health. Invasive meningococcal disease national surveillance report, with a focus on Men W. 9 January 2017 (Accessed 28 September 2017).
4 MacNeil JR, Cohn AC, Zell ER, et al. Early estimate of the effectiveness of quadrivalent meningococcal conjugate vaccine. Pediatric Infectious Disease Journal 2011;30:451-5.
5 Australian Government Department of Health Meningococcal W Disease-Information for Health Professionals Date issued: 14 December 2016 (Accessed 28 September 2017).
6 Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook, Australian Government Department of Health, Canberra, 2018, immunisation handbook.health.gov.au
7 Martin NV, Ong KS, Howden BP, et al. Rise in invasive serogroup W meningococcal disease in Australia 2013– 2015. Communicable Diseases Intelligence 2016;40: E454-E9.
8 Meningococcal Australia The Facts 2014 (Accessed website 8 August 2017).
9 Victoria State Government. Health and Human Services. Better Health Channel Meningococcal Disease Fact Sheet (Accessed 28 September 2017).
10 McCall BJ, Neill AS, Young MM. Risk factors for invasive meningococcal disease in southern Queensland, 2000–2001. Internal Medicine Journal 2004;34:464-8.
11 Centers for Disease Control and Prevention (CDC) Meningococcal Disease Causes and Transmission (page last updated 28 March 2017) Accessed 5 September 2017.
12 Christensen H. et al. 2010. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infectious Diseases Dec 2010: 853-61.
13 Meningococcal vaccines for Australians/NCIRS Fact sheet: March 2017.
14 National Notification Disease Surveillance System Annual Report Writing Group. Australia’s notifiable disease status, 2012: annual report of the National Notifiable Diseases Surveillance System. Communicable Diseases Intelligence 2015; 39: E46-E136.
15 Department of Health, Vic, ACT, NSW, Tas, QLD, SA, NT.
16 SA Health Meningococcal B Immunisation Program.
17 Therapeutic Goods Administration (TGA) Novartis Vaccines & Diagnostics Pty Ltd. Product information: BEXSERO® suspension for injection. Multicomponent meningococcal group B vaccine (recombinant, adsorbed). 2016.
18 Department of Health National Immunisation Program last update 1st July 2020.
19 Meningococcal vaccines for Australians/NCIRS Fact sheet: August 2018.
20 Lawrence GL, Wang H, Lahra M, Booy R, McIntyre PB. Meningococcal disease epidemiology in Australia 10 years after implementation of a national conjugate meningococcal C immunization programme. Epidemiology and Infection 2016; 144:2382-91.